Stay updated on Psilocybin for Major Depression Clinical Trial

Sign up to get notified when there's something new on the Psilocybin for Major Depression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin for Major Depression Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a Publications section displaying the JAMA Psychiatry article Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial (Mertens et al., 2026; doi:10.1001/jamapsychiatry.2026.0132) and a note that PubMed-sourced publications may appear.
    Difference
    0.3%
    Check dated 2026-03-25T21:19:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:11:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor version update with no changes to core study information or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-03-11T18:13:30.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page shows a minor administrative update: Revision: v3.4.2 was added and an older funding/operating-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:49:24.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A site-wide notice about potential update delays due to a lapse in government funding and the NIH Clinical Center status was added, and a revision tag 'Revision: v3.4.1' was applied.
    Difference
    0.4%
    Check dated 2026-02-04T03:39:53.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    UI and metadata updates were implemented, including a glossary toggle display, capitalization adjustments for QC-related labels, and a new 'Revision: v3.4.0' tag alongside the 'No FEAR Act Data' notice. The core study information remains unchanged, with no edits to eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:35:57.000Z thumbnail image

Stay in the know with updates to Psilocybin for Major Depression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin for Major Depression Clinical Trial page.